Recent Quotes
My Watchlist
Indicators
Local Stocks
NewsOK Local Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Abeona Therapeutics (NQ: ABEO )

1.990 USD -0.150 (-7.01%)
Official Closing Price Updated: 5:35 PM EST, Jan 20, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Abeona Therapeutics

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
ROSEN, A TOP RANKED LAW FIRM, Reminds Abeona Therapeutics Inc. Investors of Important Deadline in Securities Class Action – ABEO
From GlobeNewswire News Releases
Abeona Announces Closing of $103.5 Million Underwritten Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
From GlobeNewswire News Releases
Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Abeona Therapeutics Inc. (ABEO), AZZ, Inc. (AZZ) & Twitter, Inc. (TWTR)
From GlobeNewswire News Releases
Abeona Announces Pricing of Public Offering of Common Stock and Pre‑Funded Warrants
From GlobeNewswire News Releases
Abeona Therapeutics Receives European Medicines Agency PRIME Designation for ABO-102 Gene Therapy in MPS IIIA
PRIME is sixth regulatory designation for the ABO-102 clinical program 
From GlobeNewswire News Releases
Abeona Therapeutics Announces Public Offering of Common Stock and Pre Funded Warrants
From GlobeNewswire News Releases
Abeona Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Abeona Therapeutics Inc. To Contact The Firm
From NewMediaWire
ABEO NOTICE: Pawar Law Group Reminds Investors of JANUARY 2 Deadline in Securities Class Action Lawsuit Against Abeona Therapeutics Inc.– ABEO
From GlobeNewswire News Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Abeona Therapeutics Inc. of Class Action Lawsuit and Upcoming Deadline – ABEO
From GlobeNewswire News Releases
Abeona Shareholder Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Abeona Therapeutics Inc. To Contact The Firm
From NewMediaWire
ABEO LOSS ALERT: TOP RANKED ROSEN LAW FIRM Reminds Abeona Therapeutics Inc. Investors of Important Deadline in Securities Class Action – ABEO
From GlobeNewswire News Releases
Abeona Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Abeona Therapeutics Inc. To Contact The Firm
From NewMediaWire
Bronstein, Gewirtz & Grossman, LLC Reminds of Class Action Against Abeona Therapeutics Inc. (ABEO), AZZ, Inc. (AZZ) & Infosys Limited (INFY)
From GlobeNewswire News Releases
ABEO ALERT: Zhang Investor Law Reminds Investors of JANUARY 2 Deadline in Securities Class Action Lawsuit Against Abeona Therapeutics Inc.– ABEO
From GlobeNewswire News Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Abeona Therapeutics Inc. of Class Action Lawsuit and Upcoming Deadline – ABEO
From GlobeNewswire News Releases
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against PG&E Corporation, Twitter, Sealed Air, and Abeona Therapeutics and Encourages Investors to Contact the
From GlobeNewswire News Releases
Biotech Advancements In The Immuno-Oncology Field For Pediatric and Adult Brain Tumors
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Biotech Advancements in the Immuno-Oncology Field for Pediatric and Adult Brain Tumors
Financialnewsmedia.com News Commentary 
From PR Newswire
Pawar Law Group Reminds Investors of JANUARY 2 Deadline in Securities Class Action Lawsuit Against Abeona Therapeutics Inc. – ABEO
From GlobeNewswire News Releases
Abeona Therapeutics Cleared to Initiate Pivotal Phase 3 Clinical Trial Evaluating EB-101 Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa
From GlobeNewswire News Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Abeona Therapeutics Inc. of Class Action Lawsuit and Upcoming Deadline – ABEO
From GlobeNewswire News Releases
Bronstein, Gewirtz & Grossman, LLC Reminds of Class Action Against Abeona Therapeutics Inc. (ABEO), AZZ, Inc. (AZZ) & Bloom Energy Corporation (BE)
From GlobeNewswire News Releases
Abeona Shareholder Notice: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Abeona Therapeutics Inc. To Contact The Firm
From NewMediaWire
ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Reminds Abeona Therapeutics Inc. Investors of Important Deadline in Securities Class Action – ABEO
From GlobeNewswire News Releases
Abeona Shareholder Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Abeona Therapeutics Inc. To Contact The Firm
From NewMediaWire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Abeona, AZZ, Under Armour, and UP Fintech and Encourages Investors to Contact the Firm
From GlobeNewswire News Releases
Abeona Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Abeona Therapeutics Inc. To Contact The Firm
From NewMediaWire
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Abeona Therapeutics Inc. of Class Action Lawsuit and Upcoming Deadline – ABEO
From GlobeNewswire News Releases
NASDAQ: ABEO Shareholder Notice Investor Alert: Lawsuit Alleges Misleading Statements by Abeona Therapeutics Inc.
San Diego, CA -- (SBWIRE) -- 12/02/2019 -- A lawsuit was filed on behalf of investors in Abeona Therapeutics Inc. (NASDAQ: ABEO) shares over alleged securities laws violations. 
From SBWire - Latest Press Releases
Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Abeona Therapeutics Inc. (ABEO), AZZ, Inc. (AZZ) & Bloom Energy Corporation (BE)
From GlobeNewswire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.